Hemophilia Market Report by Type (Hemophilia A, Hemophilia B, Hemophilia C, and Others), Treatment (On-Demand, Prophylaxis), Therapy (Replacement Therapy, ITI Therapy, Gene Therapy), and Region 2025-2033

Hemophilia Market Report by Type (Hemophilia A, Hemophilia B, Hemophilia C, and Others), Treatment (On-Demand, Prophylaxis), Therapy (Replacement Therapy, ITI Therapy, Gene Therapy), and Region 2025-2033

Report Format: PDF+Excel | Report ID: SR112025A4508

1   Preface
2   Scope and Methodology

    2.1    Objectives of the Study
    2.2    Stakeholders
    2.3    Data Sources
        2.3.1    Primary Sources
        2.3.2    Secondary Sources
    2.4    Market Estimation
        2.4.1    Bottom-Up Approach
        2.4.2    Top-Down Approach
    2.5    Forecasting Methodology
3   Executive Summary
4   Introduction

    4.1    Overview
    4.2    Key Industry Trends
5   Global Hemophilia Market
    5.1    Market Overview
    5.2    Market Performance
    5.3    Impact of COVID-19
    5.4    Market Forecast
6   Market Breakup by Type
    6.1    Hemophilia A
        6.1.1 Market Trends
        6.1.2 Market Forecast
    6.2    Hemophilia B
        6.2.1 Market Trends
        6.2.2 Market Forecast
    6.3    Hemophilia C
        6.3.1 Market Trends
        6.3.2 Market Forecast
    6.4    Others
        6.4.1 Market Trends
        6.4.2 Market Forecast
7   Market Breakup by Treatment
    7.1    On-Demand
        7.1.1 Market Trends
        7.1.2 Market Forecast
    7.2    Prophylaxis
        7.2.1 Market Trends
        7.2.2 Market Forecast
8   Market Breakup by Therapy
    8.1    Replacement Therapy
        8.1.1 Market Trends
        8.1.2 Market Forecast
    8.2    ITI Therapy
        8.2.1 Market Trends
        8.2.2 Market Forecast
    8.3    Gene Therapy
        8.3.1 Market Trends
        8.3.2 Market Forecast
9   Market Breakup by Region
    9.1    North America
        9.1.1 United States
           9.1.1.1 Market Trends
           9.1.1.2 Market Forecast
        9.1.2 Canada
           9.1.2.1 Market Trends
           9.1.2.2 Market Forecast
    9.2    Asia-Pacific
        9.2.1 China
           9.2.1.1 Market Trends
           9.2.1.2 Market Forecast
        9.2.2 Japan
           9.2.2.1 Market Trends
           9.2.2.2 Market Forecast
        9.2.3 India
           9.2.3.1 Market Trends
           9.2.3.2 Market Forecast
        9.2.4 South Korea
           9.2.4.1 Market Trends
           9.2.4.2 Market Forecast
        9.2.5 Australia
           9.2.5.1 Market Trends
           9.2.5.2 Market Forecast
        9.2.6 Indonesia
           9.2.6.1 Market Trends
           9.2.6.2 Market Forecast
        9.2.7 Others
           9.2.7.1 Market Trends
           9.2.7.2 Market Forecast
    9.3    Europe
        9.3.1 Germany
           9.3.1.1 Market Trends
           9.3.1.2 Market Forecast
        9.3.2 France
           9.3.2.1 Market Trends
           9.3.2.2 Market Forecast
        9.3.3 United Kingdom
           9.3.3.1 Market Trends
           9.3.3.2 Market Forecast
        9.3.4 Italy
           9.3.4.1 Market Trends
           9.3.4.2 Market Forecast
        9.3.5 Spain
           9.3.5.1 Market Trends
           9.3.5.2 Market Forecast
        9.3.6 Russia
           9.3.6.1 Market Trends
           9.3.6.2 Market Forecast
        9.3.7 Others
           9.3.7.1 Market Trends
           9.3.7.2 Market Forecast
    9.4    Latin America
        9.4.1 Brazil
           9.4.1.1 Market Trends
           9.4.1.2 Market Forecast
        9.4.2 Mexico
           9.4.2.1 Market Trends
           9.4.2.2 Market Forecast
        9.4.3 Others
           9.4.3.1 Market Trends
           9.4.3.2 Market Forecast
    9.5    Middle East and Africa
        9.5.1 Market Trends
        9.5.2 Market Breakup by Country
        9.5.3 Market Forecast
10  SWOT Analysis
    10.1    Overview
    10.2    Strengths
    10.3    Weaknesses
    10.4    Opportunities
    10.5    Threats
11  Value Chain Analysis
12  Porters Five Forces Analysis

    12.1    Overview
    12.2    Bargaining Power of Buyers
    12.3    Bargaining Power of Suppliers
    12.4    Degree of Competition
    12.5    Threat of New Entrants
    12.6    Threat of Substitutes
13  Price Analysis
14  Competitive Landscape

    14.1    Market Structure
    14.2    Key Players
    14.3    Profiles of Key Players
        14.3.1    Baxter International Inc.
           14.3.1.1 Company Overview
           14.3.1.2 Product Portfolio
           14.3.1.3 Financials
           14.3.1.4 SWOT Analysis
        14.3.2    Bayer AG
           14.3.2.1 Company Overview
           14.3.2.2 Product Portfolio
           14.3.2.3 Financials
           14.3.2.4 SWOT Analysis
        14.3.3    BioMarin Pharmaceutical Inc.
           14.3.3.1 Company Overview
           14.3.3.2 Product Portfolio
           14.3.3.3 Financials
           14.3.3.4 SWOT Analysis
        14.3.4    CSL Behring (CSL Limited)
           14.3.4.1 Company Overview
           14.3.4.2 Product Portfolio
        14.3.5    F. Hoffmann-La Roche AG
           14.3.5.1 Company Overview
           14.3.5.2 Product Portfolio
           14.3.5.3 Financials
        14.3.6    Grifols S.A.
           14.3.6.1 Company Overview
           14.3.6.2 Product Portfolio
           14.3.6.3 Financials
           14.3.6.4 SWOT Analysis
        14.3.7    Kedrion S.p.A.
           14.3.7.1 Company Overview
           14.3.7.2 Product Portfolio
        14.3.8    Novo Nordisk A/S
           14.3.8.1 Company Overview
           14.3.8.2 Product Portfolio
           14.3.8.3 Financials
           14.3.8.4 SWOT Analysis
        14.3.9    Octapharma AG
           14.3.9.1 Company Overview
           14.3.9.2 Product Portfolio
           14.3.9.3 SWOT Analysis
        14.3.10    Pfizer Inc.
           14.3.10.1 Company Overview
           14.3.10.2 Product Portfolio
           14.3.10.3 Financials
           14.3.10.4 SWOT Analysis
        14.3.11    Sanofi S.A.
           14.3.11.1 Company Overview
           14.3.11.2 Product Portfolio
           14.3.11.3 Financials
           14.3.11.4 SWOT Analysis
        14.3.12    Takeda Pharmaceutical Company Limited
           14.3.12.1 Company Overview
           14.3.12.2 Product Portfolio
           14.3.12.3 Financials
           14.3.12.4 SWOT Analysis

List of Figures

​Figure 1: Global: Hemophilia Market: Major Drivers and Challenges
Figure 2: Global: Hemophilia Market: Sales Value (in Billion USD), 2019-2024
Figure 3: Global: Hemophilia Market Forecast: Sales Value (in Billion USD), 2025-2033
Figure 4: Global: Hemophilia Market: Breakup by Type (in %), 2024
Figure 5: Global: Hemophilia Market: Breakup by Treatment (in %), 2024
Figure 6: Global: Hemophilia Market: Breakup by Therapy (in %), 2024
Figure 7: Global: Hemophilia Market: Breakup by Region (in %), 2024
Figure 8: Global: Hemophilia (Hemophilia A) Market: Sales Value (in Million USD), 2019 & 2024
Figure 9: Global: Hemophilia (Hemophilia A) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 10: Global: Hemophilia (Hemophilia B) Market: Sales Value (in Million USD), 2019 & 2024
Figure 11: Global: Hemophilia (Hemophilia B) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 12: Global: Hemophilia (Hemophilia C) Market: Sales Value (in Million USD), 2019 & 2024
Figure 13: Global: Hemophilia (Hemophilia C) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 14: Global: Hemophilia (Other Types) Market: Sales Value (in Million USD), 2019 & 2024
Figure 15: Global: Hemophilia (Other Types) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 16: Global: Hemophilia (On-Demand) Market: Sales Value (in Million USD), 2019 & 2024
Figure 17: Global: Hemophilia (On-Demand) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 18: Global: Hemophilia (Prophylaxis) Market: Sales Value (in Million USD), 2019 & 2024
Figure 19: Global: Hemophilia (Prophylaxis) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 20: Global: Hemophilia (Replacement Therapy) Market: Sales Value (in Million USD), 2019 & 2024
Figure 21: Global: Hemophilia (Replacement Therapy) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 22: Global: Hemophilia (ITI Therapy) Market: Sales Value (in Million USD), 2019 & 2024
Figure 23: Global: Hemophilia (ITI Therapy) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 24: Global: Hemophilia (Gene Therapy) Market: Sales Value (in Million USD), 2019 & 2024
Figure 25: Global: Hemophilia (Gene Therapy) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 26: North America: Hemophilia Market: Sales Value (in Million USD), 2019 & 2024
Figure 27: North America: Hemophilia Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 28: United States: Hemophilia Market: Sales Value (in Million USD), 2019 & 2024
Figure 29: United States: Hemophilia Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 30: Canada: Hemophilia Market: Sales Value (in Million USD), 2019 & 2024
Figure 31: Canada: Hemophilia Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 32: Asia-Pacific: Hemophilia Market: Sales Value (in Million USD), 2019 & 2024
Figure 33: Asia-Pacific: Hemophilia Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 34: China: Hemophilia Market: Sales Value (in Million USD), 2019 & 2024
Figure 35: China: Hemophilia Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 36: Japan: Hemophilia Market: Sales Value (in Million USD), 2019 & 2024
Figure 37: Japan: Hemophilia Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 38: India: Hemophilia Market: Sales Value (in Million USD), 2019 & 2024
Figure 39: India: Hemophilia Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 40: South Korea: Hemophilia Market: Sales Value (in Million USD), 2019 & 2024
Figure 41: South Korea: Hemophilia Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 42: Australia: Hemophilia Market: Sales Value (in Million USD), 2019 & 2024
Figure 43: Australia: Hemophilia Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 44: Indonesia: Hemophilia Market: Sales Value (in Million USD), 2019 & 2024
Figure 45: Indonesia: Hemophilia Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 46: Others: Hemophilia Market: Sales Value (in Million USD), 2019 & 2024
Figure 47: Others: Hemophilia Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 48: Europe: Hemophilia Market: Sales Value (in Million USD), 2019 & 2024
Figure 49: Europe: Hemophilia Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 50: Germany: Hemophilia Market: Sales Value (in Million USD), 2019 & 2024
Figure 51: Germany: Hemophilia Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 52: France: Hemophilia Market: Sales Value (in Million USD), 2019 & 2024
Figure 53: France: Hemophilia Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 54: United Kingdom: Hemophilia Market: Sales Value (in Million USD), 2019 & 2024
Figure 55: United Kingdom: Hemophilia Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 56: Italy: Hemophilia Market: Sales Value (in Million USD), 2019 & 2024
Figure 57: Italy: Hemophilia Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 58: Spain: Hemophilia Market: Sales Value (in Million USD), 2019 & 2024
Figure 59: Spain: Hemophilia Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 60: Russia: Hemophilia Market: Sales Value (in Million USD), 2019 & 2024
Figure 61: Russia: Hemophilia Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 62: Others: Hemophilia Market: Sales Value (in Million USD), 2019 & 2024
Figure 63: Others: Hemophilia Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 64: Latin America: Hemophilia Market: Sales Value (in Million USD), 2019 & 2024
Figure 65: Latin America: Hemophilia Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 66: Brazil: Hemophilia Market: Sales Value (in Million USD), 2019 & 2024
Figure 67: Brazil: Hemophilia Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 68: Mexico: Hemophilia Market: Sales Value (in Million USD), 2019 & 2024
Figure 69: Mexico: Hemophilia Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 70: Others: Hemophilia Market: Sales Value (in Million USD), 2019 & 2024
Figure 71: Others: Hemophilia Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 72: Middle East and Africa: Hemophilia Market: Sales Value (in Million USD), 2019 & 2024
Figure 73: Middle East and Africa: Hemophilia Market: Breakup by Country (in %), 2024
Figure 74: Middle East and Africa: Hemophilia Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 75: Global: Hemophilia Industry: SWOT Analysis
Figure 76: Global: Hemophilia Industry: Value Chain Analysis
Figure 77: Global: Hemophilia Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: Hemophilia Market: Key Industry Highlights, 2024 and 2033
Table 2: Global: Hemophilia Market Forecast: Breakup by Type (in Million USD), 2025-2033
Table 3: Global: Hemophilia Market Forecast: Breakup by Treatment (in Million USD), 2025-2033
Table 4: Global: Hemophilia Market Forecast: Breakup by Therapy (in Million USD), 2025-2033
Table 5: Global: Hemophilia Market Forecast: Breakup by Region (in Million USD), 2025-2033
Table 6: Global: Hemophilia Market: Competitive Structure
Table 7: Global: Hemophilia Market: Key Players

Hemophilia Market Report by Type (Hemophilia A, Hemophilia B, Hemophilia C, and Others), Treatment (On-Demand, Prophylaxis), Therapy (Replacement Therapy, ITI Therapy, Gene Therapy), and Region 2025-2033
Purchase Options New Year Sale
Benefits of Customization
  • Personalize this research
  • Triangulate with your data
  • Get data as per your format and definition
  • Gain a deeper dive into a specific application, geography, customer, or competitor
  • Any level of personalization

Get in Touch With Us

UNITED STATES

Phone: +1-631-791-1145

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-714-6104

Email: sales@imarcgroup.com

Client Testimonials